Sedative use and incident cognitive decline among persons aged 75 years and older: A population-based longitudinal study

International Psychogeriatrics

Volumn 24, Issue 1, 2012, Pages 48-54

  Desplenter, Franciska ^a,b   Lavikainen, Piia ^a   Hartikainen, Sirpa ^a,c   Sulkava, Raimo ^a,d   Bell, J Simon ^a,e  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b Faculty of Pharmaceutical Sciences   (Belgium)

^c Leppavirta Health Centre   (Finland)

^d KUOPIO UNIVERSITY HOSPITAL   (Finland)

^e UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

aged; cohort studies; Finland; pharmacoepidemiology; psychotropic drugs

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; OXAZEPAM; TEMAZEPAM; ZOPICLONE;

AGED; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DEPRESSION; DRUG USE; EDUCATION; FEMALE; FINLAND; HEALTH STATUS; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; POPULATION RESEARCH; STATISTICAL SIGNIFICANCE;

AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; COGNITION DISORDERS; FEMALE; HEALTH STATUS; HUMANS; HYPNOTICS AND SEDATIVES; INTERVIEWS AS TOPIC; LINEAR MODELS; LONGITUDINAL STUDIES; MALE; NEUROPSYCHOLOGICAL TESTS; SOCIOECONOMIC FACTORS;

EID: 81955161143     PISSN: 10416102     EISSN: 1741203X     Source Type: Journal    
DOI: 10.1017/S1041610211001359     Document Type: Article

References (29)

1. Allard, J., Artero, S. and Ritchie, K. (2003). Consumption of psychotropic medication in the elderly: a re-evaluation of its effect on cognitive performance. International Journal of Geriatric Psychiatry, 18, 874-878. (Pubitemid 37294848)
2. Assem-Hilger, E., Jungwirth, S., Weissgram, S., Kirchmeyr, W., Fischer, P. and Barnas, C. (2009). Benzodiazepine use in the elderly: an indicator for inappropriately treated geriatric depression? International Journal of Geriatric Psychiatry, 24, 563-569.
3. Azad, N. A., Al Bugami, M. and Loy-English, I. (2007). Gender differences in dementia risk factors. Gender Medicine, 4, 120-129. (Pubitemid 47260316)
4. Barker, M. J., Greenwood, K. M., Jackson, M. and Crowe, S. F. (2004). Persistence of cognitive effects after withdrawal from long-term benzodiazepine use: a meta-analysis. Archives of Clinical Neuropsychology, 19, 437-454. (Pubitemid 38373546)
5. Belleville, G. (2010). Mortality hazard associated with anxiolytic and hypnotic drug use in the national population health survey. Canadian Journal of Psychiatry, 55, 558-567.
6. Byerly, M. J.,Weber,M. T., Brooks,D. L., Snow, L. R., Worley, M. A. and Lescouflair, E. (2001). Antipsychotic medications and the elderly: effects on cognition and implications for use. Drugs and Aging, 18, 45-61. (Pubitemid 32182132)
7. Dealberto, M. J., McAvay, G. J., Seeman, T. and Berkman, L. (1997). Psychotropic drug use and cognitive decline among older men and women. International Journal of Geriatric Psychiatry, 12, 567-574. (Pubitemid 27239061)
8. Dewey, M. E. and Saz, P. (2001). Dementia, cognitive impairment and mortality in persons aged 65 and over living in the community: a systematic review of the literature. International Journal of Geriatric Psychiatry, 16, 751-761. (Pubitemid 32834113)
9. Fastbom, J., Forsell, Y. and Winblad, B. (1998). Benzodiazepines may have protective effects against Alzheimer disease. Alzheimer Disease and Associated Disorders, 12, 14-17. (Pubitemid 29108157)
10. Fortin, D. et al. (2007). Factors associated with long-term benzodiazepine use among elderly women and men in Quebec. Journal of Women and Aging, 19, 37-52.
11. Hanlon, J. T. et al. (1998). Benzodiazepine use and cognitive function among community-dwelling elderly. Clinical Pharmacology and Therapeutics, 64, 684-692. (Pubitemid 29011388)
12. Kidd, P. M. (2008). Alzheimer's disease, amnestic mild cognitive impairment, and age-associated memory impairment: current understanding and progress toward integrative prevention. Alternative Medicine Review, 13, 85-115. (Pubitemid 352009500)
13. Lagnaoui, R. et al. (2002). Benzodiazepine use and risk of dementia: a nested case-control study. Journal of Clinical Epidemiology, 55, 314-318. (Pubitemid 34195529)
14. Lagnaoui, R. et al. (2004). Patterns and correlates of benzodiazepine use in the French general population. European Journal of Clinical Pharmacology, 60, 523-529. (Pubitemid 39350165)
15. Lagnaoui, R. et al. (2009). The risk of cognitive impairment in older community-dwelling women after benzodiazepine use. Age and Ageing, 39, 226-228.
16. Madhusoodanan, S. and Bogunovic, O. J. (2004). Safety of benzodiazepines in the geriatric population. Expert Opinion on Drug Safety, 3, 485-493. (Pubitemid 39242722)
17. McLachlan, A. J., Hilmer, S. N. and Le Couteur, D. (2009). Variability in response to medicines in older people: phenotypic and genotypic factors. Clinical Pharmacology and Therapeutics, 85, 431-433.
18. McShane, R., Keene, J., Gedling, K., Fairburn, C., Jacoby, R. andHope, T. (1997). Do neuroleptic drugs hasten cognitive decline in dementia? Prospective study with necropsy follow up. BMJ, 314, 266-270. (Pubitemid 27047381)
19. Moride, Y. and Abenhaim, L. (1994). Evidence of the depletion of susceptibles effect in non-experimental pharmacoepidemiologic research. Journal of Clinical Epidemiology, 47, 731-737. (Pubitemid 24236255)
20. Mossello, E. et al. (2008). Is antidepressant treatment associated with reduced cognitive decline in Alzheimer's disease? Dementia and Geriatric Cognitive Disorders, 25, 372-379. (Pubitemid 351562960)
21. Paterniti, S., Dufouil, C. and Alperovitch, A. (2002). Long-term benzodiazepine use and cognitive decline in the elderly: the Epidemiology of Vascular Aging Study. Journal of Clinical Psychopharmacology, 22, 285-293. (Pubitemid 34546844)
22. Paterniti, S., Verdier-Taillefer, M. H., Dufouil, C. and Alperovitch, A. (2002). Depressive symptoms and cognitive decline in elderly people: a longitudinal study. British Journal of Psychiatry, 181, 406-410. (Pubitemid 35333108)
23. Rikala, M., Korhonen, M. J., Sulkava, R. and Hartikainen, S. (2011). The effects of medication assessment on psychotropic drug use in the community-dwelling elderly. International Psychogeriatrics, 23, 473-484.
24. Stern, Y. (2006). Cognitive reserve and Alzheimer disease. Alzheimer Disease and Associated Disorders, 20 (Suppl. 2), S69-S74. (Pubitemid 44265854)
25. Stewart, S. A. (2005). The effects of benzodiazepines on cognition. Journal of Clinical Psychiatry, 66 (Suppl. 2), 9-13. (Pubitemid 40343675)
26. Tangalos, E. G. et al. (1996). The Mini-Mental State Examination in general medical practice: clinical utility and acceptance. Mayo Clinic Proceedings, 71, 829-837.
27. van Vliet, P., van der Mast, R. C., van den Broek, M., Westendorp, R. G. and de Craen, A. J. (2009). Use of benzodiazepines, depressive symptoms and cognitive function in old age. International Journal of Geriatric Psychiatry, 24, 500-508.
28. Verbeke, G. and Molenberghs, G. (2000). Linear Mixed Models for Longitudinal Data. New York: Springer.
29. Wright, R. M. et al. (2009). Effect of central nervous system medication use on decline in cognition in community-dwelling older adults: findings from the Health, Aging And Body Composition Study. Journal of the American Geriatrics Society, 57, 243-250.